Cargando…

Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex

Background. Multiple sclerosis (MS) is an autoimmune inflammatory disease of central nervous system (CNS). MS affects quality of Life (QOL) due to physical disability and other associated problems. Disease-modifying agents like interferon beta (IFNB) have been widely utilized in this patient populat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abolfazli, R., Hosseini, A., Gholami, Kh., Javadi, M. R., Torkamandi, H., Emami, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scholarly Research Network 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423918/ https://www.ncbi.nlm.nih.gov/pubmed/22928117 http://dx.doi.org/10.5402/2012/786526

Ejemplares similares

Cost Effectiveness Analysis of Avonex and CinnoVex in Relapsing Remitting MS
por: Najafi, Behzad, et al.
Publicado: (2015)

Quality of life in relapsing-remitting multiple sclerosis patients receiving CinnoVex compared with Avonex
por: Hatam, Nahid, et al.
Publicado: (2016)

Antibodies to Interferon beta in Patients with Multiple Sclerosis Receiving CinnoVex, Rebif, and Betaferon
por: Zare, Nasrin, et al.
Publicado: (2013)

Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta
por: Abolfazli, Roya, et al.
Publicado: (2014)

Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex)
por: Cohan, Stanley L., et al.
Publicado: (2021)

Interferon Beta-1a (AVONEX(®)) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study
por: Kleinschnitz, Christoph, et al.
Publicado: (2015)

A Vexed Question
Publicado: (1887)

The Vexed Question of Gleditschine
Publicado: (1887)

Vexed Questions in Medical Ethics
Publicado: (1858)

A randomized, controlled trial of interferon-β-1a (Avonex(®)) in patients with rheumatoid arthritis: a pilot study [ISRCTN03626626]
por: Genovese, Mark C, et al.
Publicado: (2004)

A Phase IV Study of the Safety and Efficacy of CinnoPar(®) in Iranian Patients with Osteoporosis
por: Jamshidi, Ahmadreza, et al.
Publicado: (2021)

Substrate-Dependent Activation of the Vibrio cholerae vexAB RND Efflux System Requires vexR
por: Taylor, Dawn L., et al.
Publicado: (2015)

The vexing relationship between socioeconomic status and health
por: Donahoe, J. Travis, et al.
Publicado: (2020)

Clinical utility of VExUS score for anaesthesiologists
por: Ahluwalia, Pallavi, et al.
Publicado: (2023)

An open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex(® )prefilled syringe in multiple sclerosis subjects
por: Phillips, J Theodore, et al.
Publicado: (2011)

A Comparison Study of Efficacy and Safety of a Biosimilar Form of Intramuscular Βeta-interferon I-a Versus the Reference Product: A Randomized Controlled Clinical Trial in Iran
por: Nabavi, Seyed Massood, et al.
Publicado: (2019)

Knowledge, attitudes and practice of nurse regarding adverse drug reaction reporting
por: Hanafi, Somayeh, et al.
Publicado: (2012)

Role of pharmacist counseling in pharmacotherapy quality improvement
por: Sanii, Yalda, et al.
Publicado: (2016)

The Vexing Case of Igor Shafarevich, a Russian Political Thinker
por: Berglund, Krista
Publicado: (2012)

Fibroadenoma versus phyllodes tumor: a vexing problem revisited!
por: Tummidi, Santosh, et al.
Publicado: (2020)

Pruritis: A Vexing Problem With a Promising New Therapy
por: Wetmore, James B.
Publicado: (2020)

A Vexing Question in Motor Control: The Degrees of Freedom Problem
por: Morasso, Pietro
Publicado: (2022)

Vexed causal inferences in nutritional epidemiology—call for genetic help
por: Ohukainen, Pauli, et al.
Publicado: (2021)

A phase III, randomized, two-armed, double-blind, parallel, active controlled, and non-inferiority clinical trial to compare efficacy and safety of biosimilar adalimumab (CinnoRA®) to the reference product (Humira®) in patients with active rheumatoid arthritis
por: Jamshidi, Ahmadreza, et al.
Publicado: (2017)

The evolution of gene regulation, the RNA universe, and the vexed questions of artefact and noise
por: Robertson, Miranda
Publicado: (2010)

Do addicts have free will? An empirical approach to a vexing question
por: Heyman, Gene M.
Publicado: (2017)

The Vexing Voyage of Vasopressin: The Consequences of Granting Market Exclusivity to Unapproved Drugs
por: Bendicksen, Liam, et al.
Publicado: (2022)

42nd Rencontres de Moriond Venus Express Science Workshop (VEX)
Publicado: (2007)

The Mission-Driven Venture: Business Solutions to the World s Most Vexing Social Problems
por: Lane, Marc
Publicado: (2015)

Tangles, Toxicity, and Tau Secretion in AD – New Approaches to a Vexing Problem
por: Gendreau, Kerry L., et al.
Publicado: (2013)

An educational intervention to improve nurses’ knowledge, attitude, and practice toward reporting of adverse drug reactions
por: Hanafi, Somayeh, et al.
Publicado: (2014)

Beta-interferons in multiple sclerosis
por: Aggarwal, Sourabh, et al.
Publicado: (2010)

The Evaluation of Albumin Utilization in a Teaching University Hospital in Iran
por: Jahangard-Rafsanjani, Zahra, et al.
Publicado: (2011)

Bowel Migration of Dormant Chronic Ambulatory Peritoneal Dialysis Catheter: A Vexed Problem Not Avoided by Flushing
por: Vincent, P., et al.
Publicado: (2017)

Vex-seq: high-throughput identification of the impact of genetic variation on pre-mRNA splicing efficiency
por: Adamson, Scott I., et al.
Publicado: (2018)

Evaluation of Venous Congestion Using Beside Ultrasonography by the Nephrology Consultant: The VExUS Nexus
por: Koratala, Abhilash
Publicado: (2022)

The Vibrio cholerae VexGH RND Efflux System Maintains Cellular Homeostasis by Effluxing Vibriobactin
por: Kunkle, Dillon E., et al.
Publicado: (2017)

Clinical applications of the venous excess ultrasound (VExUS) score: conceptual review and case series
por: Rola, Philippe, et al.
Publicado: (2021)

VEX1 Influences mVSG Expression During the Transition to Mammalian Infectivity in Trypanosoma brucei
por: Tihon, Eliane, et al.
Publicado: (2022)

Vexed mutations promote degeneration of dopaminergic neurons through excessive activation of the innate immune response
por: Davis, Jacinta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u6aa406dqbj009pf63kh0cis3m